Bonus BioGroup Ltd. Logo

Bonus BioGroup Ltd.

Develops cell therapies and tissue products for bone grafts and inflammation repair.

BONS | TA

Overview

Corporate Details

ISIN(s):
IL0004850116
LEI:
Country:
Israel
Address:
Park P.O.B 15143, 31905 Haifa
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Bonus BioGroup Ltd. is a clinical-stage biotechnology company specializing in regenerative medicine. The company develops investigational cell therapy and tissue engineering products to address unmet medical needs related to tissue damage, inflammation, and bone loss. Its pipeline is led by two key candidates: BonoFill, a personalized, viable bone graft engineered from a patient's own cells for orthopedic and maxillofacial applications; and MesenCure, an allogeneic cell therapy designed to target inflammation and promote tissue repair. These therapies are currently being evaluated in clinical trials for safety and efficacy.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-27 11:48
Investor Presentation
Company Presentation- 2025
Hebrew (modern) 9.0 MB
2025-05-27 11:48
Regulatory News Service
Company Presentation- 2025
Russian 43.6 KB
2023-07-11 12:06
Investor Presentation
Company Presentation, July 2023
English 3.4 MB
2023-07-11 12:06
Investor Presentation
Company Presentation, July 2023
Russian 44.7 KB
2022-04-11 16:02
Investor Presentation
Company Presentation
English 8.2 MB
2022-04-11 16:02
Registration Form
Company Presentation
Russian 47.1 KB
2022-04-11 15:01
Investor Presentation
Company Presentation
Hebrew (modern) 11.0 MB
2022-04-11 15:01
Pre-Annual General Meeting Information
Company Presentation
Russian 47.1 KB
2022-01-10 10:52
Regulatory News Service
The company inteds to publish an immediate report, trading will be open after …
Hebrew (modern) 105.1 KB

Automate Your Workflow. Get a real-time feed of all Bonus BioGroup Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bonus BioGroup Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bonus BioGroup Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Korean CRO offering end-to-end clinical trial services for pharma & bio ventures.
South Korea 187660
HYUNDAI BIOSCIENCE CO., LTD. Logo
Clinical-stage biotech developing safer antiviral & anticancer drugs via advanced drug delivery systems.
South Korea 048410
IMGT Corporation Limited Logo
Develops a drug delivery platform using ultrasound and nanotech for oncology.
South Korea 456570
Immunic AG Logo
Developing oral therapies for autoimmune diseases like multiple sclerosis and celiac disease.
United States of America IMUX
Operates one of Japan's largest ad networks and a 'Furusato Nozei' tax donation website.
Japan 6535
INBIOGEN CO.,Ltd Logo
Data mining, bioinformatics, and virtual assistance for the life sciences industry.
South Korea 101140
Incross Co.,Ltd. Logo
A digital marketing firm offering data-driven ad solutions via proprietary AI and video platforms.
South Korea 216050
INEST,Inc. Logo
Offers ASP solutions and HR support to businesses and sells mobile devices to consumers.
Japan 7111
Innate Pharma Logo
Clinical-stage biotech developing NK cell-engaging antibodies for cancer immunotherapy.
France IPH
Innovation Inc. Logo
Drives B2B growth via digital media, IT solutions, M&A advisory, and venture capital.
Japan 3970

Talk to a Data Expert

Have a question? We'll get back to you promptly.